Wal-Mart Charged Premium For Migraine Meds, Suit Says

Law360, New York (September 13, 2013, 4:49 PM EDT) -- Wal-Mart Stores Inc. was hit with a putative class action in New Jersey federal court Thursday alleging it misled consumers into paying twice as much for its store-brand Equate migraine medicine by deceptively marketing it as being more effective than its regular Equate headache medicine.

Plaintiff Bonnie Cooper alleges that both over-the-counter medications contain the same amount of active ingredients and are equally effective in treating migraine headaches, yet Wal-Mart charges consumer twice as much for the migraine version, misleading consumers to think the migraine version...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

COOPER v. WAL-MART STORES, INC.


Case Number

1:13-cv-05446

Court

New Jersey

Nature of Suit

Other Fraud

Judge

Jerome B. Simandle

Date Filed

September 12, 2013

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.